TRMT10A and central nervous system cancer: In conclusion, this study demonstrated that the expression of TRMT10A is downregulated in glioma cells, which reduces m1G9 modification of tRNA-ArgCCT, decreases tRNA stability, and upregulates tRF-22 expression.